PM012
N/A
Report date: 2023/04/19 20:00:28
NME
Base Information
Drug NamePM012
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesGmp Bio, Co Ltd
China Registration ClassN/A
Develop Information
Active CompaniesMediforum Co Ltd
Inactive CompaniesVt Bio Co Ltd
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A